|
1. Open-label study of infliximab treatment for psoriatic arthritis: clinical and magnetic resonance imaging measurements of reduction of inflammation.
Antoni C, Dechant C, Hanns-Martin Lorenz PD, Wendler J, Ogilvie A, Lueftl M, Kalden-Nemeth D, Kalden JR, Manger B.
Department of Medicine III, Friedrich-Alexander-University, Erlangen, Germany.
christian.antoni@med3.imed.uni-erlangen.de
Arthritis Rheum. 2002 Oct 15;47(5):506-12.
2. The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT)
Christian Antoni, Arthur Kavanaugh, Bruce Kirkham, Gerd Burmester, Michael Weisman, Ed Keystone, Wolfgang Ebner, Dan Furst, S Wassenberg, Mathias Grunke, Udo Schneider, Zuhre Tutuncu, Jochen Kalden, Joseph Smolen
ACR 66th Annual Scientific Meeting, New Orleans, October 25-29, 2002, Program Number: 985
3. THE INFLIXIMAB MULTINATIONAL PSORIATIC ARTHRITIS CONTROLLED TRIAL (IMPACT): SUBSTANTIAL EFFICACY ON SYNOVITIS AND PSORIATIC LESIONS WITH OR WITHOUT CONCOMITANT DMARD THERAPY
C.E. Antoni, A. Kavanaugh, B. Kirkham, G. Burmester, B. Manger, Z. Tutuncu, U. Schneider, W. Ebner, S. Wassenberg, D. Furst, J. Molitor, M. Weisman, D. Wallace, E. Keystone, J.R. Kalden, J. Smolen
EULAR Lissabon 18-21 June, 2003, Ann Rheum Dis 62 (Suppl 1)
4. Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative Study.
Clegg DO, Reda DJ, Mejias E, Cannon GW, Weisman MH, Taylor T, Budiman-Mak E, Blackburn WD, Vasey FB, Mahowald ML, Cush JJ, Schumacher HR Jr, Silverman SL, Alepa FP, Luggen ME, Cohen MR, Makkena R, Haakenson CM, Ward RH, Manaster BJ, Anderson RJ, Ward JR, Henderson WG.
VAMC, Salt Lake City, Utah, USA.
Arthritis Rheum. 1996 Dec;39(12):2013-20.
5. Comparison of sulfasalazine and placebo for the treatment of axial and peripheral articular manifestations of the seronegative spondylarthropathies: a Department of Veterans Affairs cooperative study.
Clegg DO, Reda DJ, Abdellatif M.
Salt Lake City Department of Veterans Affairs Medical Center, and University of Utah 84132, USA.
Arthritis Rheum. 1999 Nov;42(11):2325-9.
6. Interventions for psoriatic arthritis.
Jones G, Crotty M, Brooks P.
Department of Rheumatology, Menzies Centre for Population Health Res, GPO Box 252C, Hobart, Tasmania, Australia, 7001. G.Jones@Menzies.utas.edu.au
Cochrane Database Syst Rev 2000;(3):CD000212
7. Termination of disease-modifying drugs in psoriatic arthritis: study of 109 courses of treatment.
Gomez-Vaquero C, Rodriguez-Moreno J, Ros S, Marcos R, Fiter J, Roig-Escofet D.
Rheumatology Department, Ciutat Sanitaria i Universitaria de Bellvitge, Barcelona, Spain.
Br J Rheumatol 1996 Jun;35(6):564-7
8. Psoriasis as a model for T-cell-mediated disease: immunobiologic and clinical effects of treatment with multiple doses of efalizumab, an anti-CD11a antibody.
Gottlieb AB, Krueger JG, Wittkowski K, Dedrick R, Walicke PA, Garovoy M.
University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, Clinical Research Center, New Brunswick, NJ 08903-0019, USA. gottliab@UMDNJ.EDU
Arch Dermatol. 2002 May;138(5):591-600.
9. Subcutaneously Administered Efalizumab (Anti-CD11a) Improves Signs and Symptoms of Moderate to Severe Plaque Psoriasis.
Gottlieb AB, Miller B, Lowe N, Shapiro W, Hudson C, Bright R, Ling M, Magee A, McCall CO, Rist T, Dummer W, Walicke P, Bauer RJ, White M, Garovoy M.
Clinical Research Center, University of Medicine and Dentistry of New Jersey-Robert Wood Johnson Medical School, New Brunswick, New Jersey.
J Cutan Med Surg. 2003 Apr 30 [Epub ahead of print].
10. LEFLUNOMIDE (LEF) IN THE TREATMENT OF PSORIATIC ARTHRITIS AND PSORIASIS: DATA FROM A DOUBLE-BLIND, RANDOMIZED, PLACEBO- CONTROLLED CLINICAL TRIAL
J. Kaltwasserl, P. Nash, D. Gladman J, C. Rosen, F. Behrens, P. Mease, on behalf of the TOPAS Study Group
EULAR Lissabon 2003
11. Longterm therapy of psoriatic arthritis: intramuscular gold or methotrexate?
Lacaille D, Stein HB, Raboud J, Klinkhoff AV.
Mary Pack Arthritis Centre, Department of Medicine, University of British Columbia, Vancouver, Canada.
J Rheumatol 2000 Aug;27(8):1922-7
12. Efalizumab: an overview.
Leonardi CL.
Department of Dermatology, Saint Louis University School of Medicine, 1034 South Brentwood Boulevard, Suite 600, St Louis, MO 63117, USA.
J Am Acad Dermatol. 2003 Aug;49(2 Suppl):S98-104.
13. Etanercept in the treatment of psoriatic arthritis and psoriasis: a randomised trial.
Mease PJ, Goffe BS, Metz J, VanderStoep A, Finck B, Burge DJ.
Minor and James Medical, Seattle, WA 98104, USA. pmease@u.washington.edu
Lancet. 2000 Jul 29;356(9227):385-90.
14. Enbrel (etanercept) in patients with psoriatic arthritis and psoriasis
Mease PJ, Goffe BS, Metz J, et al.
Arthritis Rheum 2000; 43 (9 Suppl.): 403 [abstract no.2019]
15. A comparison of cyclosporine, sulfasalazine, and symptomatic therapy in the treatment of psoriatic arthritis.
Salvarani C, Macchioni P, Olivieri I, Marchesoni A, Cutolo M, Ferraccioli G, Cantini F, Salaffi F, Padula A, Lovino C, Dovigo L, Bordin G, Davoli C, Pasero G, Alberighi OD.
Rheumatology Service, Arcispedale S. Maria Nuova, Reggio Emilia, Italy. salvarani.carlo@asmn.re.it
J Rheumatol. 2001 Oct;28(10):2274-82.
16. Efficacy of infliximab in resistant psoriatic arthritis.
Salvarani C, Cantini F, Olivieri I, Macchioni P, Padula A, Niccoli L, Catanoso MG, Scocco GL, Boiardi L.
Arcispedale S. Maria Nuova, Reggio Emilia, Italy. salvarani.carlo@asmn.re.it
Arthritis Rheum. 2003 Aug 15;49(4):541-5.
17. Comparison of cyclosporin A and methotrexate in the treatment of psoriatic arthritis: a one-year prospective study.
Spadaro A, Riccieri V, Sili-Scavalli A, Sensi F, Taccari E, Zoppini A.
Institute of Rheumatology, University La Sapienza, Rome, Italy.
Clin Exp Rheumatol 1995 Sep-Oct;13(5):589-93
18. Effects of a loading dose regimen of three infusions of chimeric monoclonal antibody to tumour necrosis factor alpha (infliximab) in spondyloarthropathy: an open pilot study.
Van den Bosch F, Kruithof E, Baeten D, De Keyser F, Mielants H, Veys EM.
Ghent University Hospital, Department of Rheumatology, Belgium.
Ann Rheum Dis. 2000 Jun;59(6):428-33.
|
